论文部分内容阅读
目的:分析孟鲁司特联合布地奈德对于小儿哮喘的治疗效果。方法:选择我院2013年10月-2014年10月之间收治的94例哮喘患儿作为观察对象,随机分为观察组和对照组各47例。对照组采用布地奈德治疗,观察组采用孟鲁司特联合布地奈德治疗。观察对比两者的治疗效果。结果:观察组患儿的总有效率高于对照组患儿,组间的差异具有统计学意义(P<0.05)。观察组患儿中未出现复发病例,对照组中出现6例复发的患儿,组间的差异具有统计学意义(P<0.05)。结论:相对于单纯使用孟鲁斯特,应用孟鲁司特联合布地奈德治疗小儿哮喘的疗效显著、安全可靠,具有很好的临床推广应用价值。
OBJECTIVE: To analyze the therapeutic effect of montelukast combined with budesonide on pediatric asthma. Methods: A total of 94 children with asthma who were treated in our hospital from October 2013 to October 2014 were selected as observation subjects and randomly divided into observation group (47 cases) and control group (47 cases). The control group was treated with budesonide, while the observation group was treated with montelukast and budesonide. Observed and compared the therapeutic effect of both. Results: The total effective rate in observation group was higher than that in control group. The difference between the two groups was statistically significant (P <0.05). There was no recurrence in the observation group and 6 cases of recurrence in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Compared with the simple use of montelukast, montelukast combined with budesonide in the treatment of pediatric asthma significant effect, safe and reliable, with good clinical application value.